F

Amicus Therapeutics
D

FOLD

7.41000
USD
0.30
(4.22%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-62
حجم السوق
2,284,053,761
أصول ذات صلة
C
CRSP
0.853
(1.45%)
59.683 USD
E
EDIT
0.08000
(2.70%)
3.04000 USD
G
GLPG
0.650
(2.05%)
32.420 USD
N
NTLA
0.090
(0.83%)
10.995 USD
P
PTCT
0.154
(0.32%)
48.840 USD
S
SGMO
0.02420
(4.37%)
0.57800 USD
S
SRPT
1.500
(7.39%)
21.810 USD
المزيد
الأخبار المقالات

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants;a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.